| Literature DB >> 33608132 |
Alberto Larghi1, Mihai Rimbaș2, Gianenrico Rizzatti3, Carmine Carbone4, Antonio Gasbarrini5, Guido Costamagna6, Sergio Alfieri7, Giampaolo Tortora4.
Abstract
The close proximity of the endoscopic ultrasound (EUS) probe to the pancreas, coupled with the ease with which a needle can be inserted into a pancreatic lesion, have contributed to the development of EUS-guided therapies for both adenocarcinoma and neuroendocrine pancreatic neoplasms. EUS-guided fine needle injection of different types of drugs, implantation of fiducial markers to facilitate stereotactic body radiation therapy or of radioactive seeds to perform brachytherapy, and the use of different thermal and nonthermal ablation devices and techniques have all been tested in preliminary human studies. This manuscript will present the available evidence accumulated thus far in the field of EUS-guided oncological treatment of pancreatic solid tumors, along with a look into possible future applications.Entities:
Keywords: Brachytherapy; Endoscopic ultrasound; Intratumoral implantation; Intratumoral injection; Therapeutic EUS; Tumor ablation
Mesh:
Year: 2021 PMID: 33608132 DOI: 10.1053/j.seminoncol.2021.01.004
Source DB: PubMed Journal: Semin Oncol ISSN: 0093-7754 Impact factor: 4.929